Abstract
BACKGROUND: An approach based on multiparametric magnetic resonance imaging (mpMRI) might increase the detection rate (DR) of clinically significant prostate cancer (csPCa). OBJECTIVE: To compare an mpMRI-based pathway with the standard approach for the detection of prostate cancer (PCa) and csPCa. DESIGN, SETTING, AND PARTICIPANTS: Between November 2014 and April 2016, 212 biopsy-naive patients with suspected PCa (prostate specific antigen level
Original language | English |
---|---|
Pages (from-to) | 282-288 |
Number of pages | 7 |
Journal | European Urology |
Volume | 72 |
Publication status | Published - Aug 1 2017 |
Keywords
- Diagnosis, Magnetic resonance imaging, Prostate cancer, Systematic random biopsy, Targeted biopsy